How GLP-1s, Wegovy, Zepbound are reshaping the economy

Eternalcreative | Istock | Getty Images Miracle drugs, obesity treatments and skinny jabs. Call them what you will, few drugs have had a more transformative effect on Wall Street and waistlines over recent decades than GLP-1s. Familiarly known under the brand names Wegovy and Zepbound, Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medication used to…

Read More

‘Job hugging’ has replaced job hopping

Martin Barraud | OJO Images | Getty Images The so-called great resignation has become the “great stay.” But experts say workers aren’t just staying — they’re “job hugging.” Job hugging is the act of holding onto a job “for dear life,” consultants at Korn Ferry, an organizational consulting firm, wrote this week. Such clinging is…

Read More

Poor diet linked to heart disease, but Australia has seen improvements in the last 30 years

Poor diet remains the leading cause of ischemic heart disease, according to an analysis of 204 countries over a 30-year period published in Nature Medicine. The authors estimated that the suboptimal diet associated with this disease was responsible for more than 4 million ischemic heart disease-related deaths and approximately 97 million total disability-adjusted life years…

Read More

Lawmakers, health leaders make bipartisan push to expand clinical trials access

A House Democrat and Republican on Wednesday highlighted their effort to expand access to clinical trials and said artificial intelligence could be a tool that could be used to reach more underrepresented communities looking for additional treatment options. The Clinical Trials Modernization Act, co-sponsored by Representatives Raul Ruiz (D-Calif.) and Erin Houchin (R-Ind.), is a…

Read More